Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
GALT
#3040
Galectin Therapeutics Inc.
2.9
8
-1.32%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-1.32%
Monthly Change
-5.40%
6 month change
-25.87%
Cambio anual
+104.11%
Cierres anteriores
3.0
2
Open
2.9
8
Bid
Ask
Low
2.9
8
High
2.9
8
Volumen
21
Markets
Acciones
Atención Sanitaria
GALT
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Noticias
Galectin Therapeutics yönetim kurulu üyesi Marc Rubin istifa etti
Galectin Therapeutics director Marc Rubin resigns from board
Galectin Therapeutics CFO’su 233 bin dolarlık hisse satışı gerçekleştirdi
Galectin Therapeutics CFO sells $233k in shares
Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains
oracle, micron tech among market cap stock movers on friday
Galectin Therapeutics hisseleri FDA geri bildirimi sonrası sert düşüş yaşadı
Galectin Therapeutics stock plummets after FDA feedback on drug
FDA, Galectin’in belapectin geliştirme programı hakkında geri bildirim verdi
FDA provides feedback on Galectin’s belapectin development program
Galectin Therapeutics yöneticisi 1,05 milyon dolar değerinde hisse sattı
Galectin Therapeutics hissedarları yönetim kurulu üyelerini seçti ve önemli teklifleri onayladı